Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
lum001 | sodium/bile acid cotransporter | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Primary sclerosing cholangitis[MeSHID:D015209] Congenital Abnormality[MeSHID:D000013] Primary biliary cirrhosis[MeSHID:D008105] Liver[MeSHID:D008099] Bile fluid[MeSHID:D001646] Cholangitis[MeSHID:D002761] Progressive intrahepatic cholestasis (disorder)[MeSHID:C535933] |
NA | phase 2 | unknown |
lum001 | ileal sodium/bile acid cotransporter | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Primary sclerosing cholangitis[MeSHID:D015209] Congenital Abnormality[MeSHID:D000013] Primary biliary cirrhosis[MeSHID:D008105] Liver[MeSHID:D008099] Bile fluid[MeSHID:D001646] Cholangitis[MeSHID:D002761] Progressive intrahepatic cholestasis (disorder)[MeSHID:C535933] |
NA | phase 2 | unknown |
click here to return to the previous page |